Tobii AB (publ)
Tobii AB (publ) (TBIIF) Financial Performance & Income Statement Overview
Explore the financials of Tobii AB (publ) (TBIIF), including yearly and quarterly data on income, cash flow, and balance sheets.
Tobii AB (publ) (TBIIF) Income Statement & Financial Overview
Explore comprehensive income reports for Tobii AB (publ) TBIIF, broken down by year and quarter.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $284.00M | $211.00M | $201.00M | $161.00M |
| Cost of Revenue | $44.00M | $42.00M | $68.00M | $66.00M |
| Gross Profit | $240.00M | $169.00M | $133.00M | $95.00M |
| Gross Profit Ratio | $0.85 | $0.80 | $0.66 | $0.59 |
| R&D Expenses | $84.00M | $88.00M | $105.00M | $86.00M |
| SG&A Expenses | $106.00M | $104.00M | $94.00M | $90.00M |
| Operating Expenses | $190.00M | $186.00M | $199.00M | $176.00M |
| Total Costs & Expenses | $234.00M | $228.00M | $267.00M | $242.00M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $15.00M | $11.00M | $10.00M | $7.00M |
| Depreciation & Amortization | $0.00 | $12.00M | $54.00M | $48.00M |
| EBITDA | $27.00M | -$5.00M | -$8.00M | -$33.00M |
| EBITDA Ratio | $0.10 | -$0.02 | -$0.04 | -$0.20 |
| Operating Income | $50.00M | -$17.00M | -$66.00M | -$81.00M |
| Operating Income Ratio | $0.18 | -$0.08 | -$0.33 | -$0.50 |
| Other Income/Expenses (Net) | -$38.00M | $1.00M | -$7.00M | -$13.00M |
| Income Before Tax | $12.00M | -$16.00M | -$73.00M | -$88.00M |
| Income Before Tax Ratio | $0.04 | -$0.08 | -$0.36 | -$0.55 |
| Income Tax Expense | $7.00M | $1.00M | $2.00M | $1.00M |
| Net Income | $5.00M | -$17.00M | -$73.00M | -$89.00M |
| Net Income Ratio | $0.02 | -$0.08 | -$0.36 | -$0.55 |
| EPS | $0.02 | -$0.07 | -$0.31 | -$0.84 |
| Diluted EPS | $0.02 | -$0.07 | -$0.31 | -$0.84 |
| Weighted Avg Shares Outstanding | $233.68M | $233.68M | $233.61M | $106.18M |
| Weighted Avg Shares Outstanding (Diluted) | $234.09M | $234.19M | $233.61M | $106.18M |
The company's financials show resilient growth, with revenue advancing from $161.00M in Q1 2024 to $284.00M in Q4 2024. Gross profit remained healthy with margins at 85% in Q4 2024 compared to 59% in Q1 2024. Operating income hit $50.00M last quarter, sustaining a consistent 18% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $27.00M. Net income rose to $5.00M, while earnings per share reached $0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan